$1,318.00
Cachexia is a complex, multifactorial, and multi-organ metabolic syndrome found in the late stages of serious illnesses including cancer, kidney disease, and congestive heart failure.
This Market Spotlight report covers the Cachexia market, comprising epidemiology, key marketed and pipeline drugs, clinical trials, probability of success, and Licensing and Asset Acquisition Deals.
Key Takeaways
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
7 Disease definition
7 Patient segmentation
7 Symptoms
7 Risk groups
8 Diagnosis
9 TREATMENT
9 Treatment strategy
9 Drug classes
10 EPIDEMIOLOGY
10 Cancer cachexia prevalence
10 Prevalence of cachexia due to other main causes
12 MARKETED DRUGS
14 PIPELINE DRUGS
18 PROBABILITY OF SUCCESS
19 LICENSING AND ASSET ACQUISITION DEALS
19 Yuhan Acquires Majority Stake In Microbiome-Focused AtoGen
20 CLINICAL TRIAL LANDSCAPE
21 Sponsors by status
22 Sponsors by phase
24 BIBLIOGRAPHY
25 APPENDIX
LIST OF FIGURES
14 Figure 1: Overview of pipeline drugs for cachexia in the US
14 Figure 2: Pipeline drugs for cachexia, by company
15 Figure 3: Pipeline drugs for cachexia, by drug type
15 Figure 4: Pipeline drugs for cachexia, by classification
18 Figure 5: Probability of success in the metabolic-other pipeline
20 Figure 6: Clinical trials in cachexia
20 Figure 7: Top 10 drugs for clinical trials in cachexia
21 Figure 8: Top 10 companies for clinical trials in cachexia
21 Figure 9: Trial locations in cachexia
22 Figure 10: Cachexia trials status
23 Figure 11: Cachexia trials sponsors, by phase
LIST OF TABLES
9 Table 1: Drugs used for the treatment of cachexia
13 Table 2: Marketed drugs for cachexia
16 Table 3: Pipeline drugs for cachexia in the US
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!